Cetirizine for the treatment of allergic diseases in children: A systematic review and meta-analysis.

ABSTRACT:

Objective

The global prevalence of allergic diseases has led to a negative and extensive impact on the health and lives of a large population of children. This study investigates the efficacy, acceptability, and safety of cetirizine (CTZ) for treating allergic diseases in children and provides evidence-based assertions for decision-making.

Methods

PubMed, Embase, the Cochrane Library, World Health Organization International Clinical Trials Registry Platform, ClinicalTrials.gov, and the European Union Clinical Trials Register were systematically searched from inception to April 21, 2022. Randomized controlled trials (RCTs) or quasi-RCTs of children with allergic diseases receiving CTZ compared with those receiving placebo or other drugs were included without language limitati

SUBMITTER: Zhou P 

PROVIDER: S-EPMC9452751 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature